For patients with compensated MASH-related cirrhosis and obesity, metabolic surgery associated with lower risk for adverse liver outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback